SP-100030 is primarily utilized in research and development within the field of pharmacology. It functions as a selective antagonist for certain receptors, making it valuable in studying receptor mechanisms and signaling pathways. This compound is often employed in preclinical studies to investigate potential therapeutic effects, particularly in conditions related to neurological disorders or cardiovascular diseases. Its role in modulating specific biological processes helps researchers understand disease mechanisms and evaluate the efficacy of new drug candidates. Additionally, SP-100030 may be used in experimental models to assess its impact on cellular responses, aiding in the development of targeted treatments.